|
KR102160389B1
(ko)
|
2013-08-05 |
2020-09-28 |
트위스트 바이오사이언스 코포레이션 |
드 노보 합성된 유전자 라이브러리
|
|
CA2975852A1
(en)
|
2015-02-04 |
2016-08-11 |
Twist Bioscience Corporation |
Methods and devices for de novo oligonucleic acid assembly
|
|
WO2016172377A1
(en)
|
2015-04-21 |
2016-10-27 |
Twist Bioscience Corporation |
Devices and methods for oligonucleic acid library synthesis
|
|
KR20180050411A
(ko)
|
2015-09-18 |
2018-05-14 |
트위스트 바이오사이언스 코포레이션 |
올리고핵산 변이체 라이브러리 및 그의 합성
|
|
WO2017053450A1
(en)
|
2015-09-22 |
2017-03-30 |
Twist Bioscience Corporation |
Flexible substrates for nucleic acid synthesis
|
|
EP3384077A4
(en)
|
2015-12-01 |
2019-05-08 |
Twist Bioscience Corporation |
FUNCTIONALIZED SURFACES AND MANUFACTURE THEREOF
|
|
EP4357454A3
(en)
*
|
2016-03-16 |
2024-07-24 |
Immatics Biotechnologies GmbH |
Transfected t-cells and t-cell receptors for use in immunotherapy against cancers
|
|
GB201604458D0
(en)
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Peptides and combination of peptides for use in immunotherapy against cancers
|
|
WO2018038772A1
(en)
|
2016-08-22 |
2018-03-01 |
Twist Bioscience Corporation |
De novo synthesized nucleic acid libraries
|
|
EP4664304A3
(en)
|
2016-09-21 |
2026-01-21 |
Atlas Data Storage, Inc. |
Nucleic acid based data storage
|
|
MD3551221T2
(ro)
|
2016-12-08 |
2022-04-30 |
Immatics Biotechnologies Gmbh |
Noi receptori de celule T și imunoterapie cu utilizarea acestora
|
|
DE102016123847B3
(de)
|
2016-12-08 |
2018-04-05 |
Immatics Biotechnologies Gmbh |
Neue T-Zellrezeptoren und deren Verwendung in Immuntherapie
|
|
GB2573069A
(en)
*
|
2016-12-16 |
2019-10-23 |
Twist Bioscience Corp |
Variant libraries of the immunological synapse and synthesis thereof
|
|
WO2018156792A1
(en)
|
2017-02-22 |
2018-08-30 |
Twist Bioscience Corporation |
Nucleic acid based data storage
|
|
CA3056388A1
(en)
|
2017-03-15 |
2018-09-20 |
Twist Bioscience Corporation |
Variant libraries of the immunological synapse and synthesis thereof
|
|
CR20210160A
(es)
*
|
2017-04-10 |
2021-04-26 |
Immatics Biotechnologies Gmbh |
Péptidos y combinaciones de los mismos para el uso en la inmunoterapia contra diversos tipos de cáncer (divisional de solicitud 2019-0508)
|
|
WO2018231864A1
(en)
|
2017-06-12 |
2018-12-20 |
Twist Bioscience Corporation |
Methods for seamless nucleic acid assembly
|
|
IL271205B2
(en)
|
2017-06-12 |
2025-02-01 |
Twist Bioscience Corp |
Methods for assembling continuous nucleic acids
|
|
CN111566125A
(zh)
|
2017-09-11 |
2020-08-21 |
特韦斯特生物科学公司 |
Gpcr结合蛋白及其合成
|
|
CN111787930B
(zh)
*
|
2017-10-06 |
2024-12-20 |
芝加哥大学 |
针对癌症特异性抗原对t淋巴细胞的筛选
|
|
WO2019075385A1
(en)
*
|
2017-10-12 |
2019-04-18 |
Board Of Regents, The University Of Texas System |
T-LYMPHOCYTE COMPOSITIONS FOR IMMUNOTHERAPY
|
|
CN111565834B
(zh)
|
2017-10-20 |
2022-08-26 |
特韦斯特生物科学公司 |
用于多核苷酸合成的加热的纳米孔
|
|
IL312616B2
(en)
|
2018-01-04 |
2025-08-01 |
Twist Bioscience Corp |
Dna-based digital information storage
|
|
GB201803750D0
(en)
|
2018-03-08 |
2018-04-25 |
Immunocore Ltd |
Method
|
|
DE102018108612A1
(de)
|
2018-03-21 |
2019-09-26 |
Immatics US, Inc. |
Verfahren zur erhöhung der persistenz von adoptiv infundierten t-zellen
|
|
WO2019196088A1
(en)
*
|
2018-04-13 |
2019-10-17 |
Syz Cell Therapy Co. |
Methods of obtaining tumor-specific t cell receptors
|
|
EP3814497A4
(en)
|
2018-05-18 |
2022-03-02 |
Twist Bioscience Corporation |
POLYNUCLEOTIDES, REAGENTS AND METHODS FOR NUCLEIC ACID HYBRIDIZATION
|
|
US20210317184A1
(en)
*
|
2018-09-05 |
2021-10-14 |
GlaxoSmithKline Intellectual Property Devolopment Limited |
T cell modification
|
|
JP7528058B2
(ja)
*
|
2018-09-14 |
2024-08-05 |
イマティクス バイオテクノロジーズ ゲーエムベーハー |
Ｔｃｒリガンドの高スループットペプチド－ｍｈｃ親和性スクリーニングのための方法
|
|
DE102018122546B3
(de)
|
2018-09-14 |
2019-12-05 |
Immatics Biotechnologies Gmbh |
Verfahren zum Hochdurchsatz-Peptid-MHC-Affinitätsscreening für TCR-Liganden
|
|
CN112912391B
(zh)
*
|
2018-10-25 |
2026-07-03 |
昆士兰医学研究所理事会 |
T细胞受体及其用途
|
|
GB201819540D0
(en)
|
2018-11-30 |
2019-01-16 |
Adaptimmune Ltd |
T cell modification
|
|
EP3902816A4
(en)
|
2018-12-26 |
2022-09-14 |
Twist Bioscience Corporation |
HIGH-PRECISION DE NOVO POLYNUCLEOTIDE SYNTHESIS
|
|
CA3131689A1
(en)
|
2019-02-26 |
2020-09-03 |
Twist Bioscience Corporation |
Variant nucleic acid libraries for glp1 receptor
|
|
KR20210144698A
(ko)
|
2019-02-26 |
2021-11-30 |
트위스트 바이오사이언스 코포레이션 |
항체 최적화를 위한 변이 핵산 라이브러리
|
|
US20200297768A1
(en)
|
2019-03-19 |
2020-09-24 |
Immatics US, Inc. |
Cd28 t cell cultures, compositions, and methods of using thereof
|
|
DE102019108125B4
(de)
|
2019-03-28 |
2022-02-03 |
Immatics US, Inc. |
Cd28 t-zellkulturen, zusammensetzungen und verfahren zu deren verwendung
|
|
EP3714941A1
(en)
|
2019-03-27 |
2020-09-30 |
Medigene Immunotherapies GmbH |
Mage-a4 tcrs
|
|
CN111748028A
(zh)
*
|
2019-03-29 |
2020-10-09 |
天津亨佳生物科技发展有限公司 |
一种针对egfr l858r基因突变的特异性t细胞受体及其应用
|
|
CN111748029B
(zh)
*
|
2019-03-29 |
2022-12-13 |
苏州蓝马医疗技术有限公司 |
一种针对egfr l858r基因突变的特异性t细胞受体及其应用
|
|
MA55911A
(fr)
*
|
2019-05-08 |
2022-03-16 |
2Seventy Bio Inc |
Lymphocytes t génétiquement modifiés
|
|
KR20220029584A
(ko)
|
2019-05-27 |
2022-03-08 |
이매틱스 유에스 인코포레이티드 |
바이러스 벡터 및 입양 세포 요법에서 그 사용
|
|
MX2021015946A
(es)
*
|
2019-06-18 |
2022-04-18 |
Regeneron Pharma |
Receptores de linfocitos t de mage-a4 y métodos de uso de estos.
|
|
CN114245745A
(zh)
*
|
2019-06-20 |
2022-03-25 |
纪念斯隆-凯特琳癌症中心 |
靶向pik3ca突变的t细胞受体及其用途
|
|
EP3987019A4
(en)
|
2019-06-21 |
2023-04-19 |
Twist Bioscience Corporation |
Barcode-based nucleic acid sequence assembly
|
|
CN110357953B
(zh)
*
|
2019-07-17 |
2022-05-03 |
深圳市因诺转化医学研究院 |
识别人巨细胞病毒pp65抗原的TCR
|
|
KR20220052944A
(ko)
*
|
2019-07-30 |
2022-04-28 |
유니버시티 헬스 네트워크 |
Mhc 클래스 ii 분자 및 이의 사용 방법
|
|
DE102019121007A1
(de)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Antigenbindende Proteine, die spezifisch an MAGE-A binden
|
|
US20210032370A1
(en)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Recruiting agent further binding an mhc molecule
|
|
US12091777B2
(en)
|
2019-09-23 |
2024-09-17 |
Twist Bioscience Corporation |
Variant nucleic acid libraries for CRTH2
|
|
CN115023440B
(zh)
|
2019-09-23 |
2025-09-12 |
特韦斯特生物科学公司 |
结合CD3ε的抗体
|
|
AU2020400030B2
(en)
|
2019-12-09 |
2026-05-21 |
Twist Bioscience Corporation |
Variant nucleic acid libraries for adenosine receptors
|
|
AU2021206644A1
(en)
*
|
2020-01-06 |
2022-07-28 |
Memorial Hospital For Cancer And Allied Diseases |
Novel dominant negative Fas polypeptides, cells comprising thereof and uses thereof
|
|
JP2023515131A
(ja)
|
2020-02-24 |
2023-04-12 |
イマティクス ユーエス，アイエヌシー． |
がんおよび関連する悪性腫瘍の治療のためにｔ細胞を増殖させる方法
|
|
DE102020111571A1
(de)
*
|
2020-03-11 |
2021-09-16 |
Immatics US, Inc. |
Wpre-mutantenkonstrukte, zusammensetzungen und zugehörige verfahren
|
|
CN113621070A
(zh)
*
|
2020-05-06 |
2021-11-09 |
华夏英泰（北京）生物技术有限公司 |
一种t细胞抗原受体、其多聚体复合物及其制备方法和应用
|
|
WO2022040631A1
(en)
|
2020-08-21 |
2022-02-24 |
Immatics US, Inc. |
Methods for isolating cd8+ selected t cells
|
|
EP4227316A4
(en)
*
|
2020-10-07 |
2025-07-30 |
Daan Biotherapeutics Co., Ltd. |
T CELL RECEPTOR, IMMUNE CELL COMPRISING T CELL RECEPTOR, AND METHOD USING THE SAME
|
|
DE102021100038A1
(de)
|
2020-12-31 |
2022-06-30 |
Immatics US, Inc. |
Modifizierte cd8-polypeptide, zusammensetzungen und verfahren zu deren verwendung
|
|
CR20230295A
(es)
|
2020-12-31 |
2023-07-27 |
Immatics Us Inc |
Polipéptidos cd8, composiciones y métodos de uso de estos
|
|
CN115975003B
(zh)
*
|
2021-03-09 |
2024-01-26 |
科士华(南京)生物技术有限公司 |
Tcr、多肽、表达载体、宿主细胞、药物组合物和tcr获得方法
|
|
US20240168012A1
(en)
*
|
2021-03-22 |
2024-05-23 |
Juno Therapeutics, Inc. |
Methods of determining potency of a therapeutic cell composition
|
|
US20240190940A1
(en)
*
|
2021-04-21 |
2024-06-13 |
The United States of America, as represented by the Secretary, Department of Health and Human Serice |
Hla class i-restricted t cell receptors against ras with q61k mutation
|
|
KR20240004937A
(ko)
|
2021-05-05 |
2024-01-11 |
이매틱스 바이오테크놀로지스 게엠베하 |
Bma031 항원 결합 폴리펩타이드
|
|
CN113337514B
(zh)
*
|
2021-08-05 |
2021-10-29 |
卡瑞济(北京)生命科技有限公司 |
Tcr表达构建体以及其制备方法和用途
|
|
US20230089392A1
(en)
|
2021-09-20 |
2023-03-23 |
Immatics US, Inc. |
Monocyte depletion of t cells populations for t-cell therapy
|
|
WO2023047089A1
(en)
*
|
2021-09-21 |
2023-03-30 |
Oslo Universitetssykehus Hf |
Binding proteins for terminal deoxynucleotidyl transferase (tdt)
|
|
CN113773378B
(zh)
*
|
2021-10-14 |
2023-11-03 |
深圳大学总医院 |
T细胞受体及其应用
|
|
WO2023078224A1
(zh)
*
|
2021-11-03 |
2023-05-11 |
同润生物医药(上海)有限公司 |
新型抗l1cam抗体
|
|
WO2023081925A1
(en)
|
2021-11-08 |
2023-05-11 |
Immatics Biotechnologies Gmbh |
Adoptive cell therapy combination treatment and compositions thereof
|
|
US20230142468A1
(en)
|
2021-11-08 |
2023-05-11 |
Immatics US, Inc. |
Methods for generating cell spheroids
|
|
EP4463549A2
(en)
|
2022-01-14 |
2024-11-20 |
Tune Therapeutics, Inc. |
Compositions, systems, and methods for programming t cell phenotypes through targeted gene repression
|
|
US20250134999A1
(en)
|
2022-01-14 |
2025-05-01 |
Tune Therapeutics, Inc. |
Compositions, systems, and methods for programming t cell phenotypes through targeted gene activation
|
|
EP4472742A1
(en)
*
|
2022-02-03 |
2024-12-11 |
University College Cardiff Consultants Limited |
Novel t-cell receptor
|
|
WO2023183758A2
(en)
*
|
2022-03-19 |
2023-09-28 |
Regeneron Pharmaceuticals, Inc. |
Multispecific molecules targeting cd3 and mage-a4 and uses thereof
|
|
KR20250018168A
(ko)
|
2022-04-28 |
2025-02-04 |
이매틱스 유에스 인코포레이티드 |
막-결합된 il-15, cd8 폴리펩티드, 세포, 조성물, 및 이의 사용 방법
|
|
US20230348561A1
(en)
|
2022-04-28 |
2023-11-02 |
Immatics US, Inc. |
Dominant negative tgfbeta receptor polypeptides, cd8 polypeptides, cells, compositions, and methods of using thereof
|
|
WO2023212655A1
(en)
|
2022-04-28 |
2023-11-02 |
Immatics US, Inc. |
Il-12 polypeptides, il-15 polypeptides, il-18 polypeptides, cd8 polypeptides, compositions, and methods of using thereof
|
|
EP4519418A1
(en)
|
2022-05-05 |
2025-03-12 |
Immatics US, Inc. |
Methods for improving t cell efficacy
|
|
US20260085105A1
(en)
*
|
2022-06-24 |
2026-03-26 |
Amgen Inc. |
Magea4 specific t cell receptors
|
|
IL318522A
(en)
*
|
2022-07-28 |
2025-03-01 |
Hadasit Med Res Service |
Engineered T-cell receptor constructs for cancer treatment
|
|
WO2024036166A1
(en)
*
|
2022-08-08 |
2024-02-15 |
The University Of North Carolina At Chapel Hill |
Bioorthogonal t cell receptor molecules and methods of making and using the same
|
|
JP2025531268A
(ja)
|
2022-09-19 |
2025-09-19 |
チューン セラピューティクス インコーポレイテッド |
Ｔ細胞機能を調節するための組成物、システム、および方法
|
|
EP4754248A1
(en)
|
2023-07-31 |
2026-06-10 |
Tune Therapeutics, Inc. |
Compositions and methods for multiplexed activation and repression of t cell gene expression
|
|
CN121909284A
(zh)
|
2023-07-31 |
2026-04-21 |
图恩疗法股份有限公司 |
用于调节il-2基因表达的组合物和方法
|
|
US20250134931A1
(en)
|
2023-11-01 |
2025-05-01 |
Immatics US, Inc. |
Membrane-bound il-15, cd8 polypeptides, cells, compositions, and methods of using thereof
|
|
WO2025233432A1
(en)
|
2024-05-07 |
2025-11-13 |
Immatics Biotechnologies Gmbh |
Use and dosage of an antigen-binding protein comprising a tcr specific for an hla-a*02 restricted peptide
|
|
WO2026008886A1
(en)
|
2024-07-05 |
2026-01-08 |
Immatics Biotechnologies Gmbh |
Means and methods for the quantification of target expression
|
|
WO2026082746A1
(en)
|
2024-10-14 |
2026-04-23 |
Immatics Biotechnologies Gmbh |
Bispecific molecule formulation
|